VIVA-Asia Rare Tumour Board Webinar
Teratoma with Sarcomatous Transformation
Monday, 8 August 2022 | 5.30PM - 6.45PM (UTC+8 | SGT) | Check your Time Zone
VIVA-ASIA RARE TUMOUR BOARD WEBINAR is a virtual quarterly meeting that is organized by VIVA Foundation for Children with Cancer to enable doctors from all over the world to discuss the diagnosis and treatment of rare pediatric tumours.
Join us for a discussion on Teratoma with Sarcomatous Transformation. A team from KK Women and Children's Hospital from Singapore would be presenting a case on a patient who presented with anterior mediastinal mixed germ cell tumour. Dr Calvin Hoo and Dr Wai-fu Ng would be sharing the challenges of treatment while Dr Herbert Ho-fung Loong, Department of Clinical Oncology Deputy Medical Director, will enlighten us on the Implications of Somatic Transformation in Germ Cell Tumours.
Medical professionals in Singapore may eligible for CME/CPE/CNE credits for attending this webinar.
PROGRAMME TIMETABLE
PROGRAMME SYNOPSIS
Title: Mediastinal germ cell tumour with early sarcomatous transformation by KKH
A review of the clinical course and the histopathology of a 14-year-old boy with a mediastinal mixed germ cell tumour with significant mass effect. He was treated with CCLG extracranial germ cell tumour protocol with normalisation of tumour markers. Prior to planned surgical resection, he was found to have multiple bony metastasis which was biopsied and found to be positive for poorly differentiated carcinoma. Resection of anterior mediastinal mass found components of immature teratoma, yolk sac tumour and high grade angiosarcoma.
Title: Teratoma with Malignant Transformation by HKCH
Teratoma with Malignant Transformation (TMT) is a rare disease entity. Hong Kong team would be presenting on how they manage these two cases of TMT.
Title: Implications of Somatic Transformation on Germ Cell Tumours by Dr Loong, Herbert
Germ cell tumours with malignant somatic transformation represent an uncommon variant of what is typically a curable malignancy. There is a paucity of data on time of somatic transformation, response to conventional therapy, and survival outcomes of different somatic subtypes. In this talk, we aim to highlight current available evidence on this condition and discuss what may possibly be the most optimal approach in managing these patients.
WATCH IT AGAIN
SPEAKER
Dr Loong, Herbert Ho-fung
MBBS(HK), PDipMDPath(HK), MRCP(UK), FHKCP, FHKAM(Medicine) Associate Professor (Clinical) – Department of Clinical Oncology Deputy Medical Director – Phase 1 Clinical Trials Centre The Chinese University of Hong Kong, Hong Kong
Dr. Herbert Loong obtained his medical degree with a Distinction in Surgery from The University of Hong Kong in 2003. He subsequently completed his postgraduate internal medicine and medical oncology training in Queen Elizabeth Hospital and Prince of Wales Hospital in Hong Kong. He was admitted as a Member of the Royal College of Physicians (United Kingdom) in 2006 and a Fellow of the Hong Kong College of Physicians and Hong Kong Academy of Medicine in 2010.He has completed a Fellowship in Drug Development at Princess Margaret Cancer Centre in Toronto, Canada with special focuses on Experimental Therapeutics, Sarcoma Medical Oncology and Neuro-oncology. Dr. Loong joined The Chinese University of Hong Kong (CUHK) in March 2014 and is currently an Assistant Professor in the Department of Clinical Oncology, CUHK and the Deputy Medical Director of the Phase 1 Clinical Trials Centre, CUHK. He is also the Convenor of the Adult Sarcoma Multi-Disciplinary Tumour Board at Prince of Wales Hospital.His academic accolades include being the recipient of the Hong Kong Society for Neuro-oncology Traveling Scholarship in 2015 & 2016, an American Society of Clinical Oncology (ASCO) Merit Award in 2014, European Cancer Congress Fellowship Grant in 2013, European Society for Medical Oncology (ESMO) Preceptorship Award in 2012 & 2013, as well as an ESMO Translational Research Unit Visit Scholarship in 2012.
PRESENTERS
Dr Hoo, Calvin
Resident Specialist
Department of Haematology and Oncology
Hong Kong Children's Hospital, Hong Kong
Dr Amanda Kan
Consultant, Department of Pathology
Hong Kong Children’s Hospital, Hong Kong
Dr Ng, Wai-fu
Consultant Pathologist
Hong Kong Children's Hospital, Hong Kong
Dr Loh, Amos
Senior Consultant, Department of Paediatric Surgery
Deputy Division Chair, Division of Surgery
Assistant Professor, Duke NUS Medical School
KK Women’s and Children’s Hospital, Singapore
Dr Soh, Shui Yen
Head ＆ Senior Consultant Haematology/Oncology Service
Paediatric Brain and Solid Tumour Programme
KK Women's and Children's Hospital, Singapore
Dr Lee, York Tien
Consultant
Department of Paediatric Surgery
KK Women’s and Children’s Hospital, Singapore
Dr Merchant, Khurshid
Consultant Pathologist
Department of Pathology and Laboratory Medicine
KK Women’s and Children’s Hospital, Singapore
Dr Chong, Debbra
Consultant, Haematology-Oncology Service
KK Women's and Children's Hospital, Singapore
CONVENORS
Dr Liu, Anthony
MBBS, MMedSc, FHKAM (Paed)
Clinical Assistant Professor
Department of Paediatrics & Adolescent Medicine
Hong Kong Children’s Hospital
LKS Faculty of Medicine, The University of Hong Kong
Prof Chan, Godfrey
MD, DMD, MSc, LMCHK, FHKCP, FRCP(Edin), FRCPCH(UK)
Tsao Yen-Chow Endowed Professor in Paediatrics, HKU
Chief of Service, Department of Paediatrics,
Hong Kong Children’s Hospital and HKU-Shenzhen Hospital